B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Zymosan

300 PubMed studies analyzed · 2 RCTs · Evidence Score: 43

Research Domains

Zymosan has been studied across 21 research domains including 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology, 🦴 Bone & Joint, 🫁 Liver & Detox. The primary research focus is 🔬 Inflammation with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for Zymosan is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.